drugset / Trial / NCT03692637

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

NCT03692637 ↗

NaSingle-groupOpen-labelTreatment

Summary

This is a single centre、single arm、open-label,to investigate the safety and efficacy of anti-Mesothelin Car NK Cells With Epithelial ovarian cancer

Timeline

Start
2019-03
Primary completion
2020-11
Completion
2021-11

Drugs

EvaluationDrugModalityDoseRoute
Subject anti-Mesothelin Car NK Cells Cell therapy 500000 cells/kg —
Subject anti-Mesothelin Car NK Cells Cell therapy 3e+06 cells/kg —